Non-muscle-invasive Bladder Cancer

Full Text Guidelines Summary of Changes Scientific Publications & Appendices Pocket Guidelines Archive Panel

Panel

M. Burger

Regensburg (DE)
Vice-chairman
Submitted on: 21-06-2016
Company consultant
Astellas
 
BMS
 
Ipsen Pharma
 
Janssen
 
Pfizer
 
Springer, Thieme
 
Cepheid
 
Merk Sharp Dome
Company speaker honorarium
Astellas
 
BMS
 
Ipsen Pharma
 
Janseen
 
Pfizer
 
Springer, Thieme
 
Bayer

J. Palou

Barcelona (ES)
Member
Submitted on: 12-01-2017
Company consultant
Olympus
 
ALLERGAN
 
IBSA
Trial participation
Combat Medical
 
Presurgy

M. Rouprêt

Paris (FR)
Member
Submitted on: 23-11-2016
Company consultant
Lilly
 
GSK
 
Ipsen
 
Astellas
 
Takeda
 
Sanofi Pasteur
Company speaker honorarium
Roche
 
Zambon
Trial participation
GSK
 
Pfizer
 
Roche

R.J. Sylvester

Brussels (BE)
Member
Submitted on: 23-11-2016

E. Compérat

Paris (FR)
Member
Submitted on: 24-11-2016

R. Zigeuner

Graz (AT)
Member
Submitted on: 25-11-2016
Company consultant
Pfizer
Company speaker honorarium
Pfizer
 
Bayer Healthcare
 
Novartis
 
Glaxo Smithkline
 
Amgen
 
Ipsen
Fellowship, travel grants
Bayer Healthcare
 
Pfizer
 
Amgen
 
Novartis
 
Glaxo Smithkline
 
Astellas
 
Takeda

B.W.G. Van Rhijn

Amsterdam (NL)
Member
Submitted on: 23-11-2016
Company consultant
Astellas 2015

S.F. Shariat

Wien (AT)
Member
Submitted on: 20-12-2016
Ownership of patent(s)
2001 Shariat S. and Slawin K.: Methods to determine prognosis after therapy for prostate cancer. U.S. Patent Application Serial Number: Docket#60/266,976. Filed May 31, 2001
 
2001 Shariat S., Lerner S. and Slawin K.: Methods to determine prognosis after therapy for bladder cancer. U.S. Patent Application Serial Number: Docket#675.003US1. Filed June 1, 2001
 
2002 Shariat S., Slawin K., Kattan M., and Scardino P.: Pre- and posttreatment nomograms for predicting recurrence in patients with clinically localized prostate cancer that includes the blood markers interlukin-6 soluble receptor and transforming growth
 
2003 Slawin K., Kattan M., Shariat S., Stephenson A., and Scardino P.: Nomogram for predicting outcome of salvage radiotherapy for suspected local recurrence of prostate cancer after radical prostatectomy. U.S. Patent Applcation Serial Number: Docket#. Fi
 
2005 Shariat S.: \\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\
Receipt of honoraria or consultation fees
astellas
 
olympus,
 
wolff
 
ipsen
 
janssen
 
roche
Company consultant
Astellas
 
Olympus
 
Wolff
 
ipsen
 
cepheid
 
janseen
Company speaker honorarium
Lilly
 
Astellas
 
Ipsen
 
olympus
 
wolff
 
Janssen
Trial participation
Alere Inc. trials on NMP22
 
roche
 
MSD
 
bms
Receipt of grants/research supports
astellas
 
sanofi
Participation in a company sponsered speaker's bureau
bms
 
msd
 
roche
 
ipsen
 
olympus
Other
bms
speaker honorarium Receipt of honoraria or consultation fees
 
janssen
speaker honorarium Receipt of honoraria or consultation fees
 
wolff
speaker honorarium Receipt of honoraria or consultation fees
 
olympus
speaker honorarium Receipt of honoraria or consultation fees
 
astellas
speaker honorarium Receipt of honoraria or consultation fees
 
msd
speaker honorarium Receipt of honoraria or consultation fees

P. Gontero

Turin (IT)
Member
Submitted on: 07-09-2010
Company consultant
Andromedical
Trial participation
Astellas

H. Mostafid

Surrey (GB)
Member
Submitted on: 24-11-2016
Company speaker honorarium
Prostrakan
Trial participation
MSD
Spouse/partner
Combat Medical

V. Hernández Cañas

Madrid (ES)
Associate
Submitted on: 23-11-2016
Company speaker honorarium
GSK
 
Astellas
 
Janssen Pharmaceuticals
Fellowship, travel grants
IPSEN
 
Astellas
 
GSK

O. Čapoun

Prague (CZ)
Associate
Submitted on: 07-06-2016
Receipt of honoraria or consultation fees
Janssen
Company speaker honorarium
Janssen
 
Ipsen
 
Astellas
 
Bayer
Trial participation
Janssen
 
Astra Zeneca
 
Aragon Pharmaceuticals
Fellowship, travel grants
Janssen
 
Ipsen
 
Astellas

D. Cohen

London (GB)
Associate
Submitted on: 28-01-2017

J.L. Domínguez Escrig

Castellón de la Plana (ES)
Associate
Submitted on: 29-11-2016

B. Peyronnet

Rennes (FR)
Associate
Submitted on: 23-11-2016
Company consultant
Astellas
 
Boston scientific
Trial participation
Ipsen
 
Allergan

T. Seisen

Epinay sur Orge (FR)
Associate
Submitted on: 18-01-2017

V. Soukup

Prague (CZ)
Associate
Submitted on: 26-11-2016

H.M. Bruins

Nijmegen (NL)
Associate
Submitted on: 26-11-2016